Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
1.37
+0.02 (+1.48%)
Range 1.28 - 1.39
Open 1.38
Prev Close 1.35
52 Week 1.04 - 2.57
Volume 1026447
Market Cap 705.3M
*Delayed 10/23/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000